One prospective study presented showed no benefit of extended PLND, whereas a large retrospective study did point to decreased mortality after PLND.
Dr Karim Touijer et al. (Sloan Kettering Cancer Center, USA) presented a single-centre prospective RCT including 1,480 men with intermediate- to high-risk disease to assess outcomes of limited vs extended lymph node dissection in patients undergoing open, laparoscopic, and robotic prostatectomy for localised prostate cancer. No differences were observed in biochemical-free survival comparing the limited and extended dissection groups.
The patients were randomised to limited pelvic lymph node dissection (PLND; obturator fossa, n=723) or extended PLND (obturator, hypogastric, and external iliac dissection, n=757) groups, which had similar demographics including age, preoperative PSA, Gleason Grade, the presence of extracapsular extension, nodal disease, and seminal vesical invasion. The primary endpoint w...
please login to read the entire article:
You need to register to read the entire article, please do so now.
« When to Use Imaging and Imaging-guided Therapies Next Article
St. Gallen Consensus – Skin and nipple sparing surgery: still a matter of debate »
Table of Contents: EAU 2019
Renal Transplantation and Renal Cell Carcinoma
Lower Urinary Tract Symptoms
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.